1. Home
  2. AQN vs FOLD Comparison

AQN vs FOLD Comparison

Compare AQN & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Algonquin Power & Utilities Corp.

AQN

Algonquin Power & Utilities Corp.

HOLD

Current Price

$6.16

Market Cap

4.7B

Sector

Utilities

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.42

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AQN
FOLD
Founded
1988
2002
Country
Canada
United States
Employees
3786
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.5B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
AQN
FOLD
Price
$6.16
$14.42
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$6.57
$27.25
AVG Volume (30 Days)
4.4M
3.0M
Earning Date
03-06-2026
04-30-2026
Dividend Yield
4.19%
N/A
EPS Growth
N/A
50.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.34
$20.50
Revenue Next Year
$4.77
$18.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.45
$5.66
52 Week High
$7.11
$14.43

Technical Indicators

Market Signals
Indicator
AQN
FOLD
Relative Strength Index (RSI) 35.97 69.49
Support Level $5.99 $14.21
Resistance Level $6.13 N/A
Average True Range (ATR) 0.15 0.02
MACD -0.03 -0.01
Stochastic Oscillator 3.81 81.25

Price Performance

Historical Comparison
AQN
FOLD

About AQN Algonquin Power & Utilities Corp.

Algonquin Power & Utilities Corp is a Canada-based diversified international generation, transmission, and distribution company. The company's operations are organized across two business units: the Regulated Services Group, which owns and operates a portfolio of regulated electric, water distribution, and wastewater collection, and natural gas utility systems and transmission operations in the United States, Canada, Bermuda, and Chile; and the Hydro Group, which consists of hydroelectric-generating facilities located in Canada. It generates the majority of its revenue from the Regulated Services Group segment.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: